Bio-Rad Laboratories (BIO) Revenue (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Revenue data on file, last reported at $592.1 million in Q1 2026.

• On a quarterly basis, Revenue rose 1.14% year-over-year to $592.1 million in Q1 2026; TTM through Mar 2026 was $2.6 billion, a 1.92% increase from a year earlier, with the FY2025 full-year figure at $2.6 billion, up 0.65% from the prior year.
• Revenue for Q1 2026 stood at $592.1 million, down from $693.2 million in the prior quarter.
• Over the last five years, Revenue for BIO reached as high as $730.3 million in Q4 2022 and fell as low as $585.4 million in Q1 2025.
• Historically, Revenue has averaged $659.7 million across 5 years, with a median of $667.5 million in 2024.
• Across the five-year window, Revenue dropped 9.75% in 2024 and gained 3.85% in 2025, its largest moves.
• Year by year, Revenue stood at $730.3 million in 2022, then decreased by 6.72% to $681.2 million in 2023, then dropped by 2.01% to $667.5 million in 2024, then gained by 3.85% to $693.2 million in 2025, then slipped by 14.58% to $592.1 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $592.1 million in Q1 2026, $693.2 million in Q4 2025, and $653.0 million in Q3 2025.